-transparent.png){kind=logo}
Attempts to develop more effective and less toxic antineoplastic nitrosoureas are summarized. Previous research resulted in the synthesis and extensive preclinical testing of new, short-chain, water-soluble, but lipophilic compounds--1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea (HECNU) and 1-(2-chloroethyl)-1-nitroso-3-(methylene carboxamido)urea. Molecular mechanisms of reactions with biomolecules are discussed with regard to DNA alkylation and cross-linking, carbamoylation of glutathione and glutathione reductase inhibition. Results of a clinical phase-II study show that HECNU, as predicted from preclinical tests, exhibits outstanding activity in brain tumours. Future development concentrates on the use of carrier molecules for nitrosoureas. Results of an extensive structure-activity study with oestradiol-linked analogues show that an oestradiol-17 ester derivative is much more active than other analogues.
G Eisenbrand, and
N Müller, and
J Schreiber, and
W Stahl, and
W Sterzel, and
M R Berger, and
W J Zeller, and
H Fiebig
March 1990,
European journal of cancer (Oxford, England : 1990),
G Eisenbrand, and
N Müller, and
J Schreiber, and
W Stahl, and
W Sterzel, and
M R Berger, and
W J Zeller, and
H Fiebig
June 1982,
Yao xue xue bao = Acta pharmaceutica Sinica,
G Eisenbrand, and
N Müller, and
J Schreiber, and
W Stahl, and
W Sterzel, and
M R Berger, and
W J Zeller, and
H Fiebig
April 2002,
European journal of medicinal chemistry,
G Eisenbrand, and
N Müller, and
J Schreiber, and
W Stahl, and
W Sterzel, and
M R Berger, and
W J Zeller, and
H Fiebig
July 1986,
Yao xue xue bao = Acta pharmaceutica Sinica,
G Eisenbrand, and
N Müller, and
J Schreiber, and
W Stahl, and
W Sterzel, and
M R Berger, and
W J Zeller, and
H Fiebig
February 1982,
Steroids,
G Eisenbrand, and
N Müller, and
J Schreiber, and
W Stahl, and
W Sterzel, and
M R Berger, and
W J Zeller, and
H Fiebig
September 1981,
Cancer,
G Eisenbrand, and
N Müller, and
J Schreiber, and
W Stahl, and
W Sterzel, and
M R Berger, and
W J Zeller, and
H Fiebig
June 1976,
Cancer treatment reports,
G Eisenbrand, and
N Müller, and
J Schreiber, and
W Stahl, and
W Sterzel, and
M R Berger, and
W J Zeller, and
H Fiebig
January 1988,
Bulletin du cancer,
G Eisenbrand, and
N Müller, and
J Schreiber, and
W Stahl, and
W Sterzel, and
M R Berger, and
W J Zeller, and
H Fiebig
January 1989,
Annales pharmaceutiques francaises,
G Eisenbrand, and
N Müller, and
J Schreiber, and
W Stahl, and
W Sterzel, and
M R Berger, and
W J Zeller, and
H Fiebig
June 1976,
Cancer treatment reports,
